Disruptive Pharma AB (publ)
Research Disruptive Pharma AB (publ) (DPHA.ST) on Bullrun: market cap SEK 49.31M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDPHA.ST
- ExchangeSSME
- CountrySweden
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CurrencySEK
- Market capSEK 49.31M
- Financial periodQ1 2026
- RevenueSEK 589.00K
- Net income-SEK 3.37M
- Free cash flow-SEK 3.65M
Valuation Snapshot
latest market cap is SEK 49.31M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 877.00K | -SEK 19.93M | -SEK 20.79M | n/a | -0.44 | SEK 7.73M | n/a | SEK 6.85M |
| FY2024 | SEK 0 | -SEK 29.87M | -SEK 29.51M | n/a | -0.67 | SEK 19.53M | n/a | SEK 17.79M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-29 | SEK 49.31M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Disruptive Pharma AB (publ)
Disruptive Pharma AB (publ) operates as a pharmaceutical technology company in Sweden. The company develops and commercializes Formulite, a patented and clinically evaluated platform technology for oral drug formulation and drug product development. The company is based in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Disruptive Pharma AB (publ)'s market cap?
Disruptive Pharma AB (publ)'s market capitalization is SEK 49.31M.
What does Disruptive Pharma AB (publ) do?
Disruptive Pharma AB (publ) operates as a pharmaceutical technology company in Sweden. The company develops and commercializes Formulite, a patented and clinically evaluated platform technology for oral drug formulation and drug product development. The company is based in Stockholm, Sweden.